Connection

Robert Haile to Male

Back to Details
This is a "connection" page, showing publications Robert Haile has written about Male.
Robert Haile
Connection Strength
0.922
Male
  1. Endoscopic History and Provider Characteristics Influence Gastric Cancer Survival in Asian Americans. Cancer Prev Res (Phila). 2020 09; 13(9):773-782.
    View in: PubMed
    Score: 0.038
  2. Genetic variation in insulin pathway genes and distal colorectal adenoma risk. Int J Colorectal Dis. 2012 Dec; 27(12):1587-95.
    View in: PubMed
    Score: 0.022
  3. Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the Colorectal Cancer Family Registry. Cancer Prev Res (Phila). 2012 Feb; 5(2):328-35.
    View in: PubMed
    Score: 0.021
  4. Variation in folate pathway genes and distal colorectal adenoma risk: a sigmoidoscopy-based case-control study. Cancer Causes Control. 2011 Apr; 22(4):541-52.
    View in: PubMed
    Score: 0.020
  5. A candidate gene study of folate-associated one carbon metabolism genes and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2010 Jul; 19(7):1812-21.
    View in: PubMed
    Score: 0.019
  6. Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev. 2010 Feb; 19(2):525-36.
    View in: PubMed
    Score: 0.018
  7. Genetic variability in the MTHFR gene and colorectal cancer risk using the colorectal cancer family registry. Cancer Epidemiol Biomarkers Prev. 2010 Jan; 19(1):89-100.
    View in: PubMed
    Score: 0.018
  8. Genes involved with folate uptake and distribution and their association with colorectal cancer risk. Cancer Causes Control. 2010 Apr; 21(4):597-608.
    View in: PubMed
    Score: 0.018
  9. XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev. 2006 Dec; 15(12):2384-90.
    View in: PubMed
    Score: 0.015
  10. K-ras mutations in incident sporadic colorectal adenomas. Cancer. 2006 Mar 01; 106(5):1036-40.
    View in: PubMed
    Score: 0.014
  11. XRCC1 and XRCC3 polymorphisms and their role as effect modifiers of unsaturated fatty acids and antioxidant intake on colorectal adenomas risk. Cancer Epidemiol Biomarkers Prev. 2005 Mar; 14(3):609-15.
    View in: PubMed
    Score: 0.013
  12. Glutathione transferase GSTT1, broccoli, and prevalence of colorectal adenomas. Pharmacogenetics. 2002 Mar; 12(2):175-9.
    View in: PubMed
    Score: 0.011
  13. Genetic architectures of proximal and distal colorectal cancer are partly distinct. Gut. 2021 07; 70(7):1325-1334.
    View in: PubMed
    Score: 0.010
  14. Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses. BMC Med. 2020 09 03; 18(1):229.
    View in: PubMed
    Score: 0.010
  15. Exploratory Genome-Wide Interaction Analysis of Nonsteroidal Anti-inflammatory Drugs and Predicted Gene Expression on Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2020 09; 29(9):1800-1808.
    View in: PubMed
    Score: 0.010
  16. Potential impact of family history-based screening guidelines on the detection of early-onset colorectal cancer. Cancer. 2020 07 01; 126(13):3013-3020.
    View in: PubMed
    Score: 0.009
  17. Impaired Immune Health in Survivors of Diffuse Large B-Cell Lymphoma. J Clin Oncol. 2020 05 20; 38(15):1664-1675.
    View in: PubMed
    Score: 0.009
  18. Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history. Fam Cancer. 2019 10; 18(4):389-397.
    View in: PubMed
    Score: 0.009
  19. Folic acid supplementation and risk of colorectal neoplasia during long-term follow-up of a randomized clinical trial. Am J Clin Nutr. 2019 10 01; 110(4):903-911.
    View in: PubMed
    Score: 0.009
  20. Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome. Br J Cancer. 2019 11; 121(10):869-876.
    View in: PubMed
    Score: 0.009
  21. Genome-wide association study of circulating folate one-carbon metabolites. Genet Epidemiol. 2019 12; 43(8):1030-1045.
    View in: PubMed
    Score: 0.009
  22. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. Genet Med. 2020 01; 22(1):15-25.
    View in: PubMed
    Score: 0.009
  23. DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility. Int J Cancer. 2020 01 15; 146(2):363-372.
    View in: PubMed
    Score: 0.009
  24. Discovery of common and rare genetic risk variants for colorectal cancer. Nat Genet. 2019 01; 51(1):76-87.
    View in: PubMed
    Score: 0.009
  25. Cancer Risks for PMS2-Associated Lynch Syndrome. J Clin Oncol. 2018 10 10; 36(29):2961-2968.
    View in: PubMed
    Score: 0.008
  26. Physical activity and the risk of colorectal cancer in Lynch syndrome. Int J Cancer. 2018 11 01; 143(9):2250-2260.
    View in: PubMed
    Score: 0.008
  27. Incidence of lung cancer histologic cell-types according to neighborhood factors: A population based study in California. PLoS One. 2018; 13(5):e0197146.
    View in: PubMed
    Score: 0.008
  28. Worldwide Practice Patterns in Lynch Syndrome Diagnosis and?Management, Based on Data From the International Mismatch Repair Consortium. Clin Gastroenterol Hepatol. 2018 12; 16(12):1901-1910.e11.
    View in: PubMed
    Score: 0.008
  29. Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC). Int J Epidemiol. 2018 04 01; 47(2):387-388i.
    View in: PubMed
    Score: 0.008
  30. Trends in Cancer Survival by Health Insurance Status in California From 1997 to 2014. JAMA Oncol. 2018 Mar 01; 4(3):317-323.
    View in: PubMed
    Score: 0.008
  31. Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood Characteristics. J Clin Oncol. 2018 01 01; 36(1):25-33.
    View in: PubMed
    Score: 0.008
  32. The Patient Protection and Affordable Care Act dependent coverage expansion: Disparities in impact among young adult oncology patients. Cancer. 2018 Jan 01; 124(1):110-117.
    View in: PubMed
    Score: 0.008
  33. Continued Increase in Melanoma Incidence across all Socioeconomic Status Groups in California, 1998-2012. J Invest Dermatol. 2017 11; 137(11):2282-2290.
    View in: PubMed
    Score: 0.008
  34. Lung cancer incidence trends in California by race/ethnicity, histology, sex, and neighborhood socioeconomic status: An analysis spanning 28 years. Lung Cancer. 2017 06; 108:140-149.
    View in: PubMed
    Score: 0.008
  35. Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans. Int J Cancer. 2017 06 15; 140(12):2728-2733.
    View in: PubMed
    Score: 0.008
  36. Alcohol Consumption and the Risk of Colorectal Cancer for Mismatch Repair Gene Mutation Carriers. Cancer Epidemiol Biomarkers Prev. 2017 03; 26(3):366-375.
    View in: PubMed
    Score: 0.007
  37. Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2017 03; 26(3):404-412.
    View in: PubMed
    Score: 0.007
  38. Genome-Wide Interaction Analyses between Genetic Variants and Alcohol Consumption and Smoking for Risk of Colorectal Cancer. PLoS Genet. 2016 Oct; 12(10):e1006296.
    View in: PubMed
    Score: 0.007
  39. Development of prognostic signatures for intermediate-risk papillary thyroid cancer. BMC Cancer. 2016 09 15; 16(1):736.
    View in: PubMed
    Score: 0.007
  40. Fine-Mapping of Common Genetic Variants Associated with Colorectal Tumor Risk Identified Potential Functional Variants. PLoS One. 2016; 11(7):e0157521.
    View in: PubMed
    Score: 0.007
  41. Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH. Int J Cancer. 2016 10 01; 139(7):1557-63.
    View in: PubMed
    Score: 0.007
  42. Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study. Int J Cancer. 2016 Sep 01; 139(5):1081-90.
    View in: PubMed
    Score: 0.007
  43. Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. Cancer Res. 2016 09 01; 76(17):5103-14.
    View in: PubMed
    Score: 0.007
  44. Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome. Int J Epidemiol. 2016 06; 45(3):940-53.
    View in: PubMed
    Score: 0.007
  45. Determining the familial risk distribution of colorectal cancer: a data mining approach. Fam Cancer. 2016 Apr; 15(2):241-51.
    View in: PubMed
    Score: 0.007
  46. Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort. BMJ Open. 2016 Feb 19; 6(2):e010293.
    View in: PubMed
    Score: 0.007
  47. Childhood cancers in families with and without Lynch syndrome. Fam Cancer. 2015 Dec; 14(4):545-51.
    View in: PubMed
    Score: 0.007
  48. Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene. Fam Cancer. 2015 Dec; 14(4):575-83.
    View in: PubMed
    Score: 0.007
  49. Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. Sci Rep. 2015 12 01; 5:17369.
    View in: PubMed
    Score: 0.007
  50. Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors. Cancer Epidemiol Biomarkers Prev. 2016 Jan; 25(1):68-75.
    View in: PubMed
    Score: 0.007
  51. A genome-wide association study for colorectal cancer identifies a risk locus in 14q23.1. Hum Genet. 2015 Nov; 134(11-12):1249-1262.
    View in: PubMed
    Score: 0.007
  52. Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome. Gastroenterology. 2015 Nov; 149(6):1446-53.
    View in: PubMed
    Score: 0.007
  53. Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome. J Natl Cancer Inst. 2015 Sep; 107(9).
    View in: PubMed
    Score: 0.007
  54. Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotype. Cancer Epidemiol Biomarkers Prev. 2015 Aug; 24(8):1229-38.
    View in: PubMed
    Score: 0.007
  55. Mendelian randomization study of height and risk of colorectal cancer. Int J Epidemiol. 2015 Apr; 44(2):662-72.
    View in: PubMed
    Score: 0.007
  56. Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2015 Jul; 24(7):1024-31.
    View in: PubMed
    Score: 0.007
  57. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. JAMA Oncol. 2015 May; 1(2):214-21.
    View in: PubMed
    Score: 0.007
  58. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. JAMA. 2015 Mar 17; 313(11):1133-42.
    View in: PubMed
    Score: 0.007
  59. Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history. Cancer Epidemiol Biomarkers Prev. 2015 Mar; 24(3):512-519.
    View in: PubMed
    Score: 0.007
  60. Lung cancer incidence trends by histology type among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 1990-2010. Cancer Epidemiol Biomarkers Prev. 2014 Nov; 23(11):2250-65.
    View in: PubMed
    Score: 0.006
  61. A novel colorectal cancer risk locus at 4q32.2 identified from an international genome-wide association study. Carcinogenesis. 2014 Nov; 35(11):2512-9.
    View in: PubMed
    Score: 0.006
  62. Genome-wide diet-gene interaction analyses for risk of colorectal cancer. PLoS Genet. 2014 Apr; 10(4):e1004228.
    View in: PubMed
    Score: 0.006
  63. Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives. Gut. 2015 Jan; 64(1):101-10.
    View in: PubMed
    Score: 0.006
  64. A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network. Cancer Epidemiol Biomarkers Prev. 2014 Apr; 23(4):601-10.
    View in: PubMed
    Score: 0.006
  65. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology. 2014 May; 146(5):1208-11.e1-5.
    View in: PubMed
    Score: 0.006
  66. Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2013 Nov; 22(11):2094-101.
    View in: PubMed
    Score: 0.006
  67. Telomere length varies by DNA extraction method: implications for epidemiologic research. Cancer Epidemiol Biomarkers Prev. 2013 Nov; 22(11):2047-54.
    View in: PubMed
    Score: 0.006
  68. Detection of large scale 3' deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything? Fam Cancer. 2013 Sep; 12(3):563-6.
    View in: PubMed
    Score: 0.006
  69. Genetic variation in the base excision repair pathway, environmental risk factors, and colorectal adenoma risk. PLoS One. 2013; 8(8):e71211.
    View in: PubMed
    Score: 0.006
  70. Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia. Gut. 2014 May; 63(5):800-7.
    View in: PubMed
    Score: 0.006
  71. Identification of novel variants in colorectal cancer families by high-throughput exome sequencing. Cancer Epidemiol Biomarkers Prev. 2013 Jul; 22(7):1239-51.
    View in: PubMed
    Score: 0.006
  72. Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat. 2013 Mar; 34(3):490-7.
    View in: PubMed
    Score: 0.006
  73. Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers? Eur J Cancer. 2013 May; 49(7):1578-87.
    View in: PubMed
    Score: 0.006
  74. Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers. Ann Surg Oncol. 2013 Jun; 20(6):1829-36.
    View in: PubMed
    Score: 0.006
  75. Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology. 2013 Apr; 144(4):799-807.e24.
    View in: PubMed
    Score: 0.006
  76. Identification of Lynch syndrome among patients with colorectal cancer. JAMA. 2012 Oct 17; 308(15):1555-65.
    View in: PubMed
    Score: 0.006
  77. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst. 2012 Sep 19; 104(18):1363-72.
    View in: PubMed
    Score: 0.006
  78. Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer. Gut. 2013 Feb; 62(2):272-9.
    View in: PubMed
    Score: 0.005
  79. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol. 2012 Mar 20; 30(9):958-64.
    View in: PubMed
    Score: 0.005
  80. Carcinogen metabolism genes, red meat and poultry intake, and colorectal cancer risk. Int J Cancer. 2012 Apr 15; 130(8):1898-907.
    View in: PubMed
    Score: 0.005
  81. Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet. 2012 Feb; 131(2):217-34.
    View in: PubMed
    Score: 0.005
  82. Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry. J Mol Diagn. 2011 May; 13(3):271-81.
    View in: PubMed
    Score: 0.005
  83. Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. Int J Cancer. 2011 Nov 01; 129(9):2256-62.
    View in: PubMed
    Score: 0.005
  84. Genotype-environment interactions in microsatellite stable/microsatellite instability-low colorectal cancer: results from a genome-wide association study. Cancer Epidemiol Biomarkers Prev. 2011 May; 20(5):758-66.
    View in: PubMed
    Score: 0.005
  85. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut. 2011 Jul; 60(7):950-7.
    View in: PubMed
    Score: 0.005
  86. Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases. J Mol Diagn. 2011 Jan; 13(1):93-9.
    View in: PubMed
    Score: 0.005
  87. Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa. Cancer Prev Res (Phila). 2010 Dec; 3(12):1552-64.
    View in: PubMed
    Score: 0.005
  88. Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer. Clin Gastroenterol Hepatol. 2011 Jun; 9(6):497-502.
    View in: PubMed
    Score: 0.005
  89. Use of folic acid-containing supplements after a diagnosis of colorectal cancer in the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev. 2010 Aug; 19(8):2023-34.
    View in: PubMed
    Score: 0.005
  90. Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics. PLoS One. 2010 Jul 16; 5(7):e11636.
    View in: PubMed
    Score: 0.005
  91. Parent of origin effects on age at colorectal cancer diagnosis. Int J Cancer. 2010 Jul 15; 127(2):361-6.
    View in: PubMed
    Score: 0.005
  92. Genetic variation in the retinoid X receptor and calcium-sensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry. Carcinogenesis. 2010 Aug; 31(8):1412-6.
    View in: PubMed
    Score: 0.005
  93. Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res. 2010 Apr 01; 16(7):2214-24.
    View in: PubMed
    Score: 0.005
  94. Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst. 2010 Mar 17; 102(6):391-400.
    View in: PubMed
    Score: 0.005
  95. Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Clin Cancer Res. 2010 Feb 15; 16(4):1331-9.
    View in: PubMed
    Score: 0.005
  96. Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst. 2010 Feb 03; 102(3):193-201.
    View in: PubMed
    Score: 0.005
  97. Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: a study from the colon cancer family registry. Mol Genet Metab. 2010 Feb; 99(2):157-9.
    View in: PubMed
    Score: 0.005
  98. Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2745-50.
    View in: PubMed
    Score: 0.005
  99. The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol Biomarkers Prev. 2009 Aug; 18(8):2310-7.
    View in: PubMed
    Score: 0.004
  100. Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiol Biomarkers Prev. 2009 Apr; 18(4):1041-9.
    View in: PubMed
    Score: 0.004
  101. Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst. 2009 Mar 18; 101(6):432-5.
    View in: PubMed
    Score: 0.004
  102. The association of tumor microsatellite instability phenotype with family history of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2009 Mar; 18(3):967-75.
    View in: PubMed
    Score: 0.004
  103. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study. J Natl Cancer Inst. 2009 Feb 18; 101(4):267-76.
    View in: PubMed
    Score: 0.004
  104. Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology. 2009 Apr; 136(4):1251-60.
    View in: PubMed
    Score: 0.004
  105. Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk. Carcinogenesis. 2009 Mar; 30(3):472-9.
    View in: PubMed
    Score: 0.004
  106. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):3208-15.
    View in: PubMed
    Score: 0.004
  107. Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels. Cancer Epidemiol Biomarkers Prev. 2008 Oct; 17(10):2625-31.
    View in: PubMed
    Score: 0.004
  108. MTHFR genotype and colorectal adenoma recurrence: data from a double-blind placebo-controlled clinical trial. Cancer Epidemiol Biomarkers Prev. 2008 Sep; 17(9):2409-15.
    View in: PubMed
    Score: 0.004
  109. Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation. Cancer Epidemiol Biomarkers Prev. 2008 Aug; 17(8):2136-45.
    View in: PubMed
    Score: 0.004
  110. Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry. Cancer Res. 2007 Dec 01; 67(23):11128-32.
    View in: PubMed
    Score: 0.004
  111. Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2331-43.
    View in: PubMed
    Score: 0.004
  112. Accuracy of colorectal polyp self-reports: findings from the colon cancer family registry. Cancer Epidemiol Biomarkers Prev. 2007 Sep; 16(9):1898-901.
    View in: PubMed
    Score: 0.004
  113. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007 Jun 06; 297(21):2351-9.
    View in: PubMed
    Score: 0.004
  114. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology. 2007 Jul; 133(1):48-56.
    View in: PubMed
    Score: 0.004
  115. Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial. J Natl Cancer Inst. 2007 Jan 17; 99(2):129-36.
    View in: PubMed
    Score: 0.004
  116. Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States). Cancer Causes Control. 2006 Dec; 17(10):1299-304.
    View in: PubMed
    Score: 0.004
  117. Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention. J Natl Cancer Inst. 2006 Oct 18; 98(20):1494-500.
    View in: PubMed
    Score: 0.004
  118. Molecular predictors of lymph node metastasis in colon cancer: increased risk with decreased thymidylate synthase expression. J Gastrointest Surg. 2005 Dec; 9(9):1216-21; discussion 1221.
    View in: PubMed
    Score: 0.003
  119. Fat, fiber, meat and the risk of colorectal adenomas. Am J Gastroenterol. 2005 Dec; 100(12):2789-95.
    View in: PubMed
    Score: 0.003
  120. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2005 Oct; 14(10):2353-8.
    View in: PubMed
    Score: 0.003
  121. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology. 2005 Jul; 129(1):34-41.
    View in: PubMed
    Score: 0.003
  122. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 2005 Apr 27; 293(16):1979-85.
    View in: PubMed
    Score: 0.003
  123. A molecular/epidemiologic analysis of expression of cyclooxygenases 1 and 2, use of nonsteroidal antiinflammatory drugs, and risk of colorectal adenoma. Clin Colorectal Cancer. 2005 Mar; 4(6):390-5.
    View in: PubMed
    Score: 0.003
  124. Meat intake, cooking-related mutagens and risk of colorectal adenoma in a sigmoidoscopy-based case-control study. Carcinogenesis. 2005 Mar; 26(3):637-42.
    View in: PubMed
    Score: 0.003
  125. Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst. 2004 Jun 16; 96(12):921-5.
    View in: PubMed
    Score: 0.003
  126. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst. 2003 Dec 03; 95(23):1765-71.
    View in: PubMed
    Score: 0.003
  127. Neoplastic and antineoplastic effects of beta-carotene on colorectal adenoma recurrence: results of a randomized trial. J Natl Cancer Inst. 2003 May 21; 95(10):717-22.
    View in: PubMed
    Score: 0.003
  128. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003 Mar 06; 348(10):891-9.
    View in: PubMed
    Score: 0.003
  129. Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev. 2002 Jul; 11(7):622-9.
    View in: PubMed
    Score: 0.003
  130. Reliability in the classification of advanced colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2002 Jul; 11(7):660-3.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.